Barclays Reiterates “Equal Weight” Rating for CME Group (CME)
CME Group (NYSE:CME)‘s stock had its “equal weight” rating restated by stock analysts at Barclays in a report issued on Friday. They currently have a $75.00 price target on the stock, down from their previous price target of $76.00. Barclays’ target price indicates a potential upside of 1.37% from the company’s current price.
CME has been the subject of a number of other recent research reports. Analysts at Zacks upgraded shares of CME Group from an “underperform” rating to a “neutral” rating in a research note on Monday, July 14th. They now have a $74.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of CME Group from $67.50 to $68.00 in a research note on Tuesday, July 8th. They now have a “neutral” rating on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated a “hold” rating on shares of CME Group in a research note on Tuesday, June 10th. They now have a $67.50 price target on the stock, down previously from $69.50. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. CME Group presently has a consensus rating of “Hold” and an average target price of $76.90.
In other CME Group news, CAO Jill A. Harley sold 2,710 shares of the company’s stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $75.00, for a total transaction of $203,250.00. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Shares of CME Group (NYSE:CME) traded up 0.89% on Friday, hitting $74.60. 988,525 shares of the company’s stock traded hands. CME Group has a 52-week low of $66.44 and a 52-week high of $84.71. The stock’s 50-day moving average is $72.20 and its 200-day moving average is $72.60. The company has a market cap of $25.050 billion and a price-to-earnings ratio of 24.65.
CME Group (NYSE:CME) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.77 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.79 by $0.02. The company had revenue of $731.60 million for the quarter, compared to the consensus estimate of $740.64 million. During the same quarter last year, the company posted $0.93 earnings per share. CME Group’s revenue was down 10.4% compared to the same quarter last year. On average, analysts predict that CME Group will post $3.23 earnings per share for the current fiscal year.
CME Group Inc (NYSE:CME) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.